CAJ | 학술논문

肿瘤的发生发展是由一系列的分子机制所触发,靶向治疗的进展给肿瘤患者带来新的希望.西妥昔单抗通过与生长因子受体竞争性结合选择性的阻断肿瘤细胞的生长,在结直肠癌的治疗中已取得了显著疗效.
종류적발생발전시유일계렬적분자궤제소촉발,파향치료적진전급종류환자대래신적희망.서타석단항통과여생장인자수체경쟁성결합선택성적조단종류세포적생장,재결직장암적치료중이취득료현저료효.
In recent years,with the development of molecular biology,people gradually realize the tumor is composed of a series of development of the molecular mechanisms that trigger.The progress of targeted therapy for cancer patients brings new hope.Cetuximab through competitive combination with growth factor receptor blocking selective the growth of tumor cells,and achieved significant results.This is cetuximab in colo rectal cancer research progress of targeted therapy are reviewed in this paper.